United States Biotechnology & Medical Research

Provention Bio Inc (PRVB)

Track

Ticker: PRVB Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Provention Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 14 Apr 2023
Value US$2,352,372.81 | Price 315.61 | Shares 69,230 (+29.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-18 2023-04-14 S Sale
Sessa Capital (Master), L.P.
Large shareholder
69,230 +29.7%
315.61
US$2,352,373 		69,230 +29.7% 315.61 US$2,352,373
2023-02-14 2023-02-13 PlS Planned sale
3.5
Palmer Ashleigh

Director and CEO

Executive Director
40,451 +9.3%
64.74
US$679,281 		40,451 +9.3% 64.74 US$679,281
2023-02-14 2023-02-13 PlS Planned sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
63,901 -32.1%
364.68
US$3,023,836 		63,901 -32.1% 364.68 US$3,023,836
2023-02-14 2023-02-10 PlS Planned sale
3.5
Palmer Ashleigh

Director and CEO

Executive Director
50,000 -1.9%
10.11
US$505,555 		50,000 -1.9% 10.11 US$505,555
2023-02-14 2023-02-10 PlS Planned sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
50,000 -3.1%
10.11
US$505,605 		50,000 -3.1% 10.11 US$505,605
2023-02-14 2023-02-10 PlS Planned sale
3.5
Hoitt Jason

Chief Commercial Officer

Officer
4,500 -100.0%
10.00
US$45,005 		4,500 -100.0% 10.00 US$45,005
2023-01-20 2023-01-18 PlS Planned sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
24,015 -1.5%
10.27
US$246,584 		24,015 -1.5% 10.27 US$246,584
2023-01-20 2023-01-18 PlS Planned sale
3.5
Palmer Ashleigh

Director and CEO

Executive Director
24,165 -0.9%
10.27
US$248,063 		24,165 -0.9% 10.27 US$248,063
2023-01-20 2023-01-18 S Sale
Sessa Capital (Master), L.P.
Large shareholder
3,000,000 -20.2%
9.40
US$28,200,000 		3,000,000 -20.2% 9.40 US$28,200,000
2022-12-30 2022-12-29 S Sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
187,000 -10.6%
10.26
US$1,918,601 		187,000 -10.6% 10.26 US$1,918,601
2022-12-29 2022-12-27 S Sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
10,674 -0.7%
10.00
US$106,740 		10,674 -0.7% 10.00 US$106,740
2022-12-27 2022-12-23 S Sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
375 -0.0%
10.00
US$3,750 		375 -0.0% 10.00 US$3,750
2022-12-27 2022-12-22 S Sale
3.3
Leon Francisco

Chief Scientific Officer

Officer
1,568 -0.1%
10.00
US$15,681 		1,568 -0.1% 10.00 US$15,681
2021-12-06 2021-12-03 B Purchase
3.0
Ramos Eleanor

Chief Medical Officer

Officer
5,201 +8.0%
6.49
US$33,765 		5,201 +8.0% 6.49 US$33,765
2021-12-01 2021-11-30 B Purchase
3.5
Palmer Ashleigh

Director and CEO

Executive Director
3,750 +0.1%
6.66
US$24,990 		3,750 +0.1% 6.66 US$24,990
2021-11-29 2021-11-24 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Officer
5,550 +0.2%
7.24
US$40,188 		5,550 +0.2% 7.24 US$40,188
2020-09-02 2020-09-02 B Purchase
3.0
Ramos Eleanor

Chief Medical Officer

Officer
299 +0.5%
12.06
US$3,606 		299 +0.5% 12.06 US$3,606
2020-09-02 2020-09-02 B Purchase
3.6
Drechsler Andrew T

Chief Financial Officer

Officer
2,000 +11.1%
11.72
US$23,440 		2,000 +11.1% 11.72 US$23,440
2020-08-21 2020-08-21 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Officer
2,000 +0.1%
13.35
US$26,708 		2,000 +0.1% 13.35 US$26,708
2020-08-20 2020-08-20 B Purchase
3.0
Ramos Eleanor

Chief Medical Officer

Officer
2,500 +4.0%
13.23
US$33,075 		2,500 +4.0% 13.23 US$33,075
2020-08-18 2020-08-18 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
500 +0.0%
12.69
US$6,345 		500 +0.0% 12.69 US$6,345
2020-08-17 2020-08-17 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
2,800 +0.1%
12.83
US$35,924 		2,800 +0.1% 12.83 US$35,924
2020-08-13 2020-08-13 B Purchase
3.6
Drechsler Andrew T

Chief Financial Officer

Officer
1,750 +10.8%
13.01
US$22,768 		1,750 +10.8% 13.01 US$22,768
2020-06-24 2020-06-24 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Officer
2,000 +0.1%
15.43
US$30,862 		2,000 +0.1% 15.43 US$30,862
2020-03-20 2020-03-19 B Purchase
3.5
Hoitt Jason

Chief Commercial Officer

Officer
4,500 +inf%
5.43
US$24,435 		4,500 +inf% 5.43 US$24,435
2020-03-20 2020-03-19 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Officer
10,000 +0.4%
5.92
US$59,200 		10,000 +0.4% 5.92 US$59,200
2019-12-26 2019-12-26 B Purchase
1.5
Ramos Eleanor

CMO & COO

Officer
2,000 +3.3%
14.34
US$28,680 		2,000 +3.3% 14.34 US$28,680
2019-12-23 2019-12-20 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
2,075 +0.1%
11.39
US$23,634 		2,075 +0.1% 11.39 US$23,634
2019-12-16 2019-12-16 B Purchase Leon Francisco

Chief Scientific Officer

Officer
2,000 +0.1%
11.92
US$23,840 		2,000 +0.1% 11.92 US$23,840
2019-09-30 2019-09-30 B Purchase
3.3
Leon Francisco

Chief Scientific Officer
1,450 +0.1%
7.67
US$11,122 		1,450 +0.1% 7.67 US$11,122
2019-09-30 2019-09-30 B Purchase
3.4
DIGIANDOMENICO ANTHONY
30,000 +20.2%
6.83
US$204,900 		30,000 +20.2% 6.83 US$204,900
2019-09-26 2019-09-26 B Purchase
3.4
DIGIANDOMENICO ANTHONY
5,000 +3.5%
8.44
US$42,200 		5,000 +3.5% 8.44 US$42,200
2019-09-25 2019-09-25 B Purchase
3.4
DIGIANDOMENICO ANTHONY
5,000 +3.6%
8.39
US$41,950 		5,000 +3.6% 8.39 US$41,950
2019-09-24 2019-09-24 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
3,000 +0.1%
8.38
US$25,140 		3,000 +0.1% 8.38 US$25,140
2019-08-09 2019-08-08 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +7.8%
9.09
US$90,900 		10,000 +7.8% 9.09 US$90,900
2019-08-09 2019-08-08 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Officer
2,500 +0.1%
9.09
US$22,725 		2,500 +0.1% 9.09 US$22,725
2019-08-09 2019-08-08 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
10,600 +0.4%
9.15
US$96,990 		10,600 +0.4% 9.15 US$96,990
2019-06-20 2019-06-20 B Purchase
3.4
DIGIANDOMENICO ANTHONY
10,000 +8.4%
10.96
US$109,600 		10,000 +8.4% 10.96 US$109,600
2019-06-18 2019-06-18 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
4,000 +0.2%
10.83
US$43,320 		4,000 +0.2% 10.83 US$43,320
2019-06-18 2019-06-18 B Purchase
3.4
DIGIANDOMENICO ANTHONY
10,000 +9.2%
10.88
US$108,800 		10,000 +9.2% 10.88 US$108,800
2019-06-17 2019-06-17 B Purchase
3.4
DIGIANDOMENICO ANTHONY
25,000 +29.9%
12.16
US$304,000 		25,000 +29.9% 12.16 US$304,000
2019-06-17 2019-06-17 S Sale
1.8
Bluestone Jeffrey
7,300 -49.9%
11.93
US$87,089 		7,300 -49.9% 11.93 US$87,089
2019-01-02 2018-12-31 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Executive Director
10,000 +0.4%
1.64
US$16,400 		10,000 +0.4% 1.64 US$16,400
2018-12-31 2018-12-31 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
825 +0.0%
1.58
US$1,304 		825 +0.0% 1.58 US$1,304
2018-12-31 2018-12-28 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director
5,000 +0.2%
1.73
US$8,650 		5,000 +0.2% 1.73 US$8,650
2018-12-31 2018-12-28 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +13.6%
1.76
US$17,600 		10,000 +13.6% 1.76 US$17,600
2018-12-31 2018-12-28 B Purchase
3.0
Pisano Wayne
Non-Executive Director
5,000 +200.0%
1.80
US$9,000 		5,000 +200.0% 1.80 US$9,000
2018-12-28 2018-12-27 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
20,000 +37.2%
1.95
US$39,000 		20,000 +37.2% 1.95 US$39,000
2018-12-27 2018-12-26 B Purchase
3.6
CATLIN AVERY W
Non-Executive Director
5,000 +33.3%
1.85
US$9,250 		5,000 +33.3% 1.85 US$9,250
2018-12-27 2018-12-24 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
17,270 +47.4%
1.92
US$33,158 		17,270 +47.4% 1.92 US$33,158
2018-12-27 2018-12-24 B Purchase
3.6
CATLIN AVERY W
Non-Executive Director
5,000 +50.0%
1.90
US$9,500 		5,000 +50.0% 1.90 US$9,500
2018-12-26 2018-12-21 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
2,000 +5.8%
1.85
US$3,700 		2,000 +5.8% 1.85 US$3,700
2018-12-21 2018-12-20 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
5,000 +17.0%
1.96
US$9,800 		5,000 +17.0% 1.96 US$9,800
2018-12-06 2018-12-03 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
4,442 +17.8%
2.45
US$10,883 		4,442 +17.8% 2.45 US$10,883
2018-12-03 2018-11-30 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
4,849 +24.1%
2.45
US$11,880 		4,849 +24.1% 2.45 US$11,880
2018-12-03 2018-11-29 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
151 +0.8%
2.47
US$373 		151 +0.8% 2.47 US$373
2018-11-28 2018-11-27 B Purchase
3.4
DIGIANDOMENICO ANTHONY
Non-Executive Director
10,000 +100.0%
2.46
US$24,600 		10,000 +100.0% 2.46 US$24,600
2018-11-27 2018-11-26 B Purchase DIGIANDOMENICO ANTHONY Non-Executive Director
10,000 +inf%
2.65
US$26,500 		10,000 +inf% 2.65 US$26,500
2018-11-13 2018-11-09 B Purchase CATLIN AVERY W Non-Executive Director
10,000 +inf%
3.15
US$31,500 		10,000 +inf% 3.15 US$31,500
2018-07-26 2018-07-19 B Purchase APPEL PETER A Large shareholder
750,000 +62.5%
4.00
US$3,000,000 		750,000 +62.5% 4.00 US$3,000,000
2018-07-19 2018-07-19 B Purchase Pisano Wayne Non-Executive Director
2,500 +inf%
4.00
US$10,000 		2,500 +inf% 4.00 US$10,000
2018-07-19 2018-07-19 B Purchase
3.3
Leon Francisco

Chief Scientific Officer

Executive Director Large shareholder
37,500 +1.5%
4.00
US$150,000 		37,500 +1.5% 4.00 US$150,000
2018-07-19 2018-07-19 B Purchase Drechsler Andrew T

Chief Financial Officer

Officer
6,250 +inf%
4.00
US$25,000 		6,250 +inf% 4.00 US$25,000
2018-07-19 2018-07-19 B Purchase
3.5
Palmer Ashleigh

President and CEO

Executive Director Large shareholder
37,500 +1.5%
4.00
US$150,000 		37,500 +1.5% 4.00 US$150,000
2018-07-19 2018-07-19 B Purchase
1.5
Ramos Eleanor

Chief Medical Officer & COO

Officer
60,000 +inf%
4.00
US$240,000 		60,000 +inf% 4.00 US$240,000
Explore more

More insider trading research around Provention Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America